demonstrated the increased BACE1 levels in the plasma of AD and MCI patients (Vmean < 2 mFu/min/μg) compared to the control (Vmean > 2.6 mFu/min/μg).41 The gene discussed is BACE1; the disease is Alzheimer disease.